InsiderClue
Stocks · Health care · Pharmaceutical Preparations

SOLIGENIX, INC.

SNGX Clue Score28
United States Fiscal year ends December CIK 0000812796
$0.36 +4.90% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.36 −66.64% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue10.4Operating income−5.7Net income−3.2EPS, diluted−1.34Fiscal year 2017Revenue5.4 −48.0%Operating income−7.6Net income−7.1EPS, diluted−1.16Fiscal year 2018Revenue5.2 −3.5%Operating income−9.1Net income−8.9Fiscal year 2019Revenue4.6 −11.7%Operating income−10.5Net income−9.4Fiscal year 2020Revenue2.4 −49.0%Operating income−18.6Net income−17.7EPS, diluted−0.64Fiscal year 2021Revenue0.8 −65.1%Operating income−13.1Net income−12.6EPS, diluted−4.69Fiscal year 2022Revenue0.9 +15.1%Operating income−14.2Net income−13.8EPS, diluted−4.81Fiscal year 2023Revenue0.8 −11.5%Operating income−7.7Net income−6.1EPS, diluted−12.66Fiscal year 2024Revenue0.1 −85.8%Operating income−9.4Net income−8.3EPS, diluted−4.98Fiscal year 2025Operating income−11.8Net income−11.1EPS, diluted−2.14
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 10.4 5.4 5.2 4.6 2.4 0.8 0.9 0.8 0.1 n/a
Growth −48.0% −3.5% −11.7% −49.0% −65.1% +15.1% −11.5% −85.8%
Operating income −5.7 −7.6 −9.1 −10.5 −18.6 −13.1 −14.2 −7.7 −9.4 −11.8
Net income −3.2 −7.1 −8.9 −9.4 −17.7 −12.6 −13.8 −6.1 −8.3 −11.1
Growth
EPS, diluted −1.34 −1.16 n/a n/a −0.64 −4.69 −4.81 −12.66 −4.98 −2.14

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Gross margin19.3%Operating margin−54.6%Net margin−31.1%Fiscal year 2017Gross margin20.7%Operating margin−139.8%Net margin−131.6%Fiscal year 2018Gross margin12.3%Operating margin−172.8%Net margin−169.8%Fiscal year 2019Gross margin22.9%Operating margin−227.7%Net margin−202.1%Fiscal year 2020Gross margin22.8%Operating margin−787.7%Net margin−749.7%Fiscal year 2021Gross margin11.6%Operating margin−1,589.2%Net margin−1,522.7%Fiscal year 2022Gross margin42.0%Operating margin−1,500.6%Net margin−1,454.1%Fiscal year 2023Gross margin11.6%Operating margin−917.1%Net margin−731.6%Fiscal year 2024Operating margin−7,907.7%Net margin−6,925.1%Fiscal year 2025
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 19.3% 20.7% 12.3% 22.9% 22.8% 11.6% 42.0% 11.6% n/a n/a
Operating margin −54.6% −139.8% −172.8% −227.7% −787.7% −1,589.2% −1,500.6% −917.1% −7,907.7% n/a
Net margin −31.1% −131.6% −169.8% −202.1% −749.7% −1,522.7% −1,454.1% −731.6% −6,925.1% n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−5.0Fiscal year 2017Operating cash flow−6.5Fiscal year 2018Operating cash flow−7.2Fiscal year 2019Operating cash flow−7.5Fiscal year 2020Operating cash flow−11.5Fiscal year 2021Operating cash flow−11.7Fiscal year 2022Operating cash flow−12.6Fiscal year 2023Operating cash flow−8.6Fiscal year 2024Operating cash flow−8.4Fiscal year 2025Operating cash flow−10.3Capital expenditure−0.0Free cash flow−10.3
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −5.0 −6.5 −7.2 −7.5 −11.5 −11.7 −12.6 −8.6 −8.4 −10.3
Capital expenditure n/a n/a n/a n/a n/a n/a n/a n/a n/a −0.0
Free cash flow n/a n/a n/a n/a n/a n/a n/a n/a n/a −10.3
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash8.8Shareholders’ equity7.4Fiscal year 2017Cash7.8Shareholders’ equity6.3Fiscal year 2018Cash9.0Shareholders’ equity6.3Fiscal year 2019Cash5.4Shareholders’ equity1.5Fiscal year 2020Cash18.7Shareholders’ equity3.7Fiscal year 2021Cash26.0Shareholders’ equity10.7Fiscal year 2022Cash13.4Total debt0.0Net cash (debt)13.4Shareholders’ equity−2.5Fiscal year 2023Cash8.4Total debt1.0Net cash (debt)7.4Shareholders’ equity2.5Debt to equity0.40Fiscal year 2024Cash7.8Total debt0.0Net cash (debt)7.8Shareholders’ equity4.1Debt to equity0.00Fiscal year 2025Cash7.9Shareholders’ equity5.3
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 8.8 7.8 9.0 5.4 18.7 26.0 13.4 8.4 7.8 7.9
Total debt n/a n/a n/a n/a n/a n/a 0.0 1.0 0.0 n/a
Net cash (debt) n/a n/a n/a n/a n/a n/a 13.4 7.4 7.8 n/a
Shareholders’ equity 7.4 6.3 6.3 1.5 3.7 10.7 −2.5 2.5 4.1 5.3
Debt to equity n/a n/a n/a n/a n/a n/a n/a 0.40 0.00 n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Margins
19.3% 20.7% 12.3% 22.9% 22.8% 11.6% 42.0% 11.6% n/a n/a
−54.6% −139.8% −172.8% −227.7% −787.7% −1,589.2% −1,500.6% −917.1% −7,907.7% n/a
−36.1% −139.2% −169.8% −215.3% −785.2% −1,627.6% −1,575.8% −942.2% −7,267.8% n/a
−31.1% −131.6% −169.8% −202.1% −749.7% −1,522.7% −1,454.1% −731.6% −6,925.1% n/a
Spending
41.1% 101.4% 128.8% 175.4% 415.2% 993.1% 837.2% 394.7% 4,375.9% n/a
32.8% 59.1% 56.3% 75.2% 183.5% 607.7% 705.3% 534.0% 3,531.8% n/a
Returns
−43.9% −113.1% −141.7% −642.1% −472.7% −117.1% n/a −243.4% −200.7% −209.4%
−31.6% −74.8% −84.8% −120.3% −88.9% −46.7% −96.6% −62.7% −92.2% −120.0%
Balance and payout
n/a n/a n/a n/a n/a n/a n/a 0.40 0.00 n/a
n/a n/a 40.1% 81.3% 81.2% 60.1% 117.3% 74.3% 54.1% 42.7%